WITNESSETH:Employment Agreement • May 14th, 1999 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
andAsset Purchase Agreement • December 28th, 1995 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • New York
Confidential Treatment Requested. Confidential portions of this document have been redacted and have been filed separately with the Commission. LICENSE AGREEMENT by and between CHARLES S. LIEBER, M.D.License Agreement • February 14th, 2001 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • New York
LEASE ----- ARTICLE I ------------------Lease - • February 14th, 1997 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF CPEC LLCLimited Liability Company Agreement • July 29th, 1999 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
ISDA(R) International Swap Dealers Association, Inc.Master Agreement • May 15th, 1997 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECTION 1 REGISTRATION RIGHTSRegistration Rights Agreement • January 31st, 1996 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
WITNESSETH:Employment Agreement • May 14th, 1999 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
SUPPLY AGREEMENTSupply Agreement • February 14th, 2003 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALSLicense Agreement • December 13th, 2001 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.95 AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • May 15th, 1998 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by * and [ ], have been separately filed with the Commission. Ex. 10.78 CONTRACT MANUFACTURING AGREEMENT This Agreement is...Interneuron Pharmaceuticals Inc • March 13th, 1996 • Pharmaceutical preparations • Connecticut
EXHIBIT 10.125 CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION LICENSE AGREEMENT by and between ATLANTIC TECHNOLOGY VENTURES, INC.License Agreement • August 14th, 2002 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENTConfidential Treatment • December 13th, 2001 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations
BETWEENRoyalty Agreement • October 2nd, 1998 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
INDEVUS PHARMACEUTICALS, INC. 7,000,000 Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2006 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.10 FORM OF INDEMNIFICATION AGREEMENT This INDEMNIFICATION AGREEMENT, made and entered into as of the 6th day of October, 1997 ("Agreement"), by and between Interneuron Pharmaceuticals, Inc., a Delaware corporation (the "Corporation"), and...Form of Indemnification Agreement • December 30th, 1997 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.97 LICENSE AGREEMENT This License Agreement (the "Agreement") dated April 29, 1998 (the "Effective Date") is by and between the Administrators of the Tulane Educational Fund, the corporate entity of the Tulane University, a non-profit...License Agreement • August 14th, 1998 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXHIBIT INDEX 10.72 Sponsored Research and License Agreement dated as of May 1, 1995 between Progenitor, Inc. and Novo Nordisk* * Confidentiality requested for a portion of this Exhibit. Exhibit 10.72 Portions of this Exhibit have been omitted...Research and License Agreement • October 3rd, 1995 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 20.1 Contact: Intercardia: W. Bennett Love 1-919-558-1907 Knoll AG: Monika Enzenbach 49-621-589-2319 For Immediate Release: Intercardia and Knoll Announce Agreement for International Development of Heart Failure Drug Research Triangle Park,...Interneuron Pharmaceuticals Inc • January 7th, 1997 • Pharmaceutical preparations
EXHIBIT 10.95a WAIVER AND CONSENT AGREEMENT This Waiver and Consent Agreement is entered into this 8th day of May 1998 by and among Intercardia, Inc., a Delaware corporation ("Intercardia"), Transcell Technologies, Inc., a Delaware corporation...Waiver and Consent Agreement • May 15th, 1998 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations
RESEARCH COLLABORATION AND LICENSE AGREEMENT by and among MERCK & CO., INC., TRANSCELL TECHNOLOGIES, INC. and INTERNEURON PHARMACEUTICALS, INC.Research Collaboration and License Agreement • August 14th, 1997 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
Ex. 10.12(e) CONSENT AND AMENDMENT AGREEMENT AGREEMENT pursuant to the provisions of the Letter of Intent dated February 10, 1995 and signed between LES LABORATOIRES SERVIER, ORSEM, AMERICAN HOME PRODUCTS CORPORATION, AMERICAN CYANAMID COMPANY and...Consent and Amendment Agreement • December 28th, 1995 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations
INDENTURE dated as of August 26, 2008 by and between LEDGEMONT ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, as initial trustee of the Notes described hereinIndenture • December 11th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • New York
This INDENTURE, dated as of August 26, 2008, is by and between LEDGEMONT ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as initial trustee of the Notes described herein.
EXHIBIT 10.112 -------------- CONSENT TO SUBLEASE THIS CONSENT TO SUBLEASE (this "Consent") is dated as of July 9, 1999, is made with reference to that certain sublease dated April 28, 1997 (the "Original Sublease"), as amended on May __, 1999 (the...Interneuron Pharmaceuticals Inc • August 4th, 1999 • Pharmaceutical preparations
Exhibit 10.85 Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions, marked by a * and [ ], have been separately filed with the Commission. AMENDMENT NO. 1 TO MASTER CONSULTING AGREEMENT The...Interneuron Pharmaceuticals Inc • December 12th, 1996 • Pharmaceutical preparations
OCTREOTIDE CONTINGENT STOCK RIGHTS AGREEMENT by and between INDEVUS PHARMACEUTICALS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY as Rights AgentContingent Stock Rights Agreement • April 17th, 2007 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This OCTREOTIDE CONTINGENT STOCK RIGHTS AGREEMENT (this “Agreement”), dated as of April 17, 2007, is entered into by and between Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and AMERICAN STOCK TRANSFER & TRUST COMPANY, as Rights Agent (the “Rights Agent”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • November 30th, 2007 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of , 2007, between Indevus Pharmaceuticals, Inc., a Delaware Corporation having a place of business at 33 Hayden Avenue, Lexington, Massachusetts 02421 (the “Corporation”) and Bobby W. Sandage, Jr., an individual residing at (the “Executive”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 14th, 2005 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This INDEMNIFICATION AGREEMENT, made and entered into as of the day of , 20 (“Agreement”), by and between Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Corporation”), and (“Indemnitee”):
VOTING AGREEMENTVoting Agreement • December 12th, 2006 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
VOTING AGREEMENT (this “Agreement”), dated as of December 11, 2006, by and among Indevus Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Hayden Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and the stockholder party hereto (the “Stockholder”).
EXHIBIT 10.108 EXCHANGE AGREEMENT This EXCHANGE AGREEMENT is entered into as of July 15, 1999, between INTERCARDIA, INC., a Delaware corporation ("Intercardia"), and INTERNEURON PHARMACEUTICALS, INC., a Delaware corporation ("Interneuron"). All terms...Exchange Agreement • July 29th, 1999 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 7th, 2009 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Amendment to Amended and Restated Employment Agreement (the “Amendment”) is entered into as of December 19, 2008 (the “Effective Date”), by and between Indevus Pharmaceuticals, Inc. (the “Company”) and Noah D. Beerman (“Executive”).
AGREEMENT AND PLAN OF MERGER BY AND AMONG ENDO PHARMACEUTICALS HOLDINGS INC. BTB PURCHASER INC. AND INDEVUS PHARMACEUTICALS, INC. DATED AS OF JANUARY 5, 2009Agreement and Plan of Merger • January 6th, 2009 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of January 5, 2009, is by and among Endo Pharmaceuticals Holdings Inc., a Delaware corporation (“Parent”), BTB Purchaser Inc. a Delaware corporation and a direct, wholly-owned Subsidiary of Parent (“Merger Sub”), and Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
Please confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below for that purpose. ___________________________________________ "INVESTOR" By:________________________________________ Print...Stock Purchase Agreement • January 3rd, 2002 • Interneuron Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
RETENTION AGREEMENTRetention Agreement • April 15th, 2008 • Indevus Pharmaceuticals Inc • Pharmaceutical preparations
AGREEMENT by and between Indevus Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Michael W. Rogers (the “Executive”), effective as of April 11, 2008 (the “Effective Date”).
